Description (Description)
Topiramate Tablet, Film Coated
Product Images NDC 80425-0214
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 80425-0214). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fig 1 (Fig 1)
The image seems to show a chart represented by a graph with two lines showing the cumulative rates for time to first seizure. The chart compares topiramate at 50 mg/day to topiramate at 400 mg/day. The graph shows that the rate of seizures is lower for the group taking topiramate at 400 mg/day compared to those taking 50 mg/day. The p-value is significant at 0.0002 indicating that the difference is statistically significant. The X-axis represents time in days, with the values ranging from 0 to 400. The Y-axis shows the cumulative rates of time to first seizure, with values ranging from 0.0 to 0.5.*
Fig 2 (Fig 2)
Label 1 (Topiramate 80425 0214 02)
This is a description of a medication package containing Topiramate 50mg tablets. The package contains 60 tablets and was packed by "Advancedrx Srn" with an identification number of "2025 0877". The National Drug Code (NDC) is 80425-0214-03 and the source is NOC: 29300-0116-16. The Lot number is 0000 and the expiration date is 9130/3034. The serial number of the package is 600000123570.*
Image (Image)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
